abstract |
This invention relates to thrombin inhibiting compounds haveing thenFormula In X-Y-NH-(CH 2 ) r -G nwhere X, Y, r and G have the values defined in the description, as well asnpharmaceutical formulations containing those compounds and methods ofntheir use as thrombin inhibitors, coagulation inhibitors, and thromboembolicndisorder agents. |